Perrone, E.; Tudisco, R.; Pafundi, P.C.; Guido, D.; Ciucci, A.; Martinelli, E.; Zannoni, G.F.; Piermattei, A.; Spadola, S.; Ferrante, G.;
et al. What’s beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study. Cancers 2022, 14, 4588.
https://doi.org/10.3390/cancers14194588
AMA Style
Perrone E, Tudisco R, Pafundi PC, Guido D, Ciucci A, Martinelli E, Zannoni GF, Piermattei A, Spadola S, Ferrante G,
et al. What’s beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study. Cancers. 2022; 14(19):4588.
https://doi.org/10.3390/cancers14194588
Chicago/Turabian Style
Perrone, Emanuele, Riccardo Tudisco, Pia Clara Pafundi, Davide Guido, Alessandra Ciucci, Enrica Martinelli, Gian Franco Zannoni, Alessia Piermattei, Saveria Spadola, Giulia Ferrante,
and et al. 2022. "What’s beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study" Cancers 14, no. 19: 4588.
https://doi.org/10.3390/cancers14194588
APA Style
Perrone, E., Tudisco, R., Pafundi, P. C., Guido, D., Ciucci, A., Martinelli, E., Zannoni, G. F., Piermattei, A., Spadola, S., Ferrante, G., Marchetti, C., Scambia, G., Fagotti, A., & Gallo, D.
(2022). What’s beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study. Cancers, 14(19), 4588.
https://doi.org/10.3390/cancers14194588
